# Six things to watch in stocks this week

> Earnings season kicks off with bank results and inflation data that could sway the Fed's next move on interest rates.
- Title: Six things to watch in stocks this week · CNBC | Shortify
- Summary: Earnings season kicks off with bank results and inflation data that could sway the Fed's next move on interest rates. Four Club holdings report earnings this…
- Keywords: earnings season, inflation reports, federal reserve, interest rates, goldman sachs, wells fargo, bank of new york, johnson and johnson, stock market, business, finance, Six
- Source: CNBC — https://cnbc.com/investingclub/2026/10/11/here-are-the-6-big-things-were-watching-in-the-stock-market-this-week.html
- Author: Zev Fima,Kevin Stankiewicz
- Published: 2026-10-11T19:46:05+00:00
- Read time: 3 min
- Topics: earnings season, inflation reports, federal reserve, interest rates, goldman sachs, wells fargo, bank of new york, johnson and johnson, stock market, business, finance
## Earnings and inflation collide
Four Club holdings report earnings this week. Two main inflation reports also arrive. Management commentary on quarterly results matters more than monthly economic data for stock investors navigating markets.
## Fed focus: inflation, not jobs
Fed Chairman Kevin Warsh has made clear his focus is on inflation, not employment. Market odds favour the Fed holding rates steady in October after its first rate increase in three years last month.
## Consumer prices Wednesday morning
September consumer price index arrives Wednesday morning. Economists polled by FactSet expect a year-over-year headline CPI increase of three point six percent, slightly hotter than August's three point four percent gain.
## Core inflation stays flat
Excluding food and energy, September core CPI is expected to rise by two point four percent, the same increase as August. The Fed's inflation target, elusive for years, is two percent.
## Wholesale prices Thursday
Producer price index arrives Thursday morning. It measures price pressures companies face across supply chains. Cost dynamics affect profit margins and can indicate where consumer prices may be heading.
## Goldman Sachs kicks off Tuesday
Goldman Sachs reports quarterly results Tuesday morning. The Street is looking for third-quarter earnings per share of thirteen dollars and two cents and revenue of sixteen point seven four billion dollars.
## Goldman: M and A and IPO appetite
Goldman's results will reveal how the high-rate environment has impacted corporate funding for mergers and acquisitions and for private companies looking to go public. Analysts expect equities trading to outpace FICC.

> Looking at the past 70 quarters of data, 2Q26 was the first time equities trading totaled more than FICC. We expect that trend to persist.
## Wells Fargo: consumer health check
Wells Fargo reports Tuesday.The Street is looking for earnings per share of one dollar and eighty five cents on revenue of twenty two point three two billion dollars.
## Wells: rates cut both ways
High rates raise yields banks receive but increase competition for deposits and funding costs. How Wells balances this dynamic, along with loan and deposit growth, will determine net interest margins and net interest income outlook.
## Bank of New York Thursday
BNY, the world's largest custodian bank, reports Thursday. The Street is looking for earnings of two dollars and twenty seven cents on revenue of five point five five billion dollars. A position added last week.
## BNY: fees and Trump Accounts
BNY's fees should benefit from rising asset prices. Analysts see net interest income benefiting from deposit growth and higher rates. Trump Accounts, tax-advantaged investment and savings accounts for kids under eighteen, are a tailwind.
## Johnson and Johnson Tuesday
J and J reports Tuesday.The Street is looking for earnings of two dollars and fifty three cents on revenue of twenty five point two five billion dollars.
## J and J: Icotyde momentum matters
Focus is on J and J's Innovative Medicine pharma segment, particularly whether Icotyde, its new oral psoriasis drug launched this spring, has picked up momentum.

> this can be one of its best-selling drugs of all time
## J and J: surgical robot and divestiture
Within J and J's MedTech segment, focus is on whether its cardiovascular portfolio is getting back on track.
## J and J investor day December eighth
J and J has an investor day planned for December eighth, representing another catalyst for shares on the other side of earnings. This follows this week's quarterly results.
## Key takeaway

Four Club holdings report earnings this week alongside two inflation reports. Market focus is on management guidance and economic data that could influence Federal Reserve rate decisions at its October meeting.